Stroke & Sleep Flashcards
mini stroke due to brief blockage of blood flow to the brain with temporary symptoms that go away quickly
transient ischemic attack
modifiable risk factors for stroke
hypertension, hyperlipidemia, smokinh, diabetes, Afib, CAD, obesity, post-menopausal hormonal therapy
nonmodifiable stroke risk factors
age >55, black/hispanic race, male FH, PH of stroke
most important piece of history for med administration for stroke
when was the last time they were normal
symptoms of stroke
visual changes, facial droop, motor function of arms/legs, limb ataxia, sensory changes, language, dysarthria
therapeutic time window for stroke for reversible deficits
<2 hours
therapeutic time window for stroke for some but incomplete recovery
2-6 hours
therapeutic time window for stroke for little recovery
> 6 hours
BP goals for someone who is not a candidate for thrombolytics
permissive HTN up to 220 mmHg systolic
2 choices of thrombolytics for stroke
alteplase (TPA)
tenecteplase (TNK)
AE of thrombolytics
intracerebral hemorrhage
BP goals while on thrombolytics
systolic <180 mmHg and diastolic <110 mmHg for 24 hours
IV agents for BP management for thromboloytics
labetalol and nicardipine
main reasons TNK differs from TPA
bolus only, longer half life
symptoms of a bleed from thrombolytics
acute neurologic change, HA, NV, acute HTN, lethargy
inclusion criteria for thrombolytics
ischemic stroke diagnosis
symptoms onset <4.5 hr prior to treatment
18 or older
deficit measured on NIHSS
CT w/ no evidence of ICH
when does 3 hours become the cutoff for thrombolytics
80 or older, severe stroke
2 main B&W exclusion criteria for thrombolytics
seizure at stroke onset
anticoagulants in the last 48 hours
drug class chosen for stroke prophylaxis when a small vessel lacunar, large vessel embolic, or large vessel thrombotic stroke
antiplatelet therapy
drug class chosen for stroke prophylaxis when cardioembolic
anticoagulant
MOA of clopidogrel & ticagrelor
irreversibly blocks ADP receptors on platelets
MOA of aspirin
inhibits COX1 and thromboxane
why is prasugrel not used for stroke
BBW/CI for stroke
increased risk for cerebral hemorrhage
plavix is a prodrug activated by _ & __ which can lead to DDIs
CYP3A4 & 2C19